 Ann-Christine Nyquist
Concepts (261)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Influenza, Human | 13 | 2024 | 615 | 1.830 |
Why?
| | Cross Infection | 9 | 2025 | 262 | 1.230 |
Why?
| | Respiratory Tract Infections | 9 | 2025 | 396 | 1.210 |
Why?
| | Infection Control | 6 | 2025 | 171 | 1.100 |
Why?
| | Surgical Wound Infection | 6 | 2023 | 316 | 0.670 |
Why?
| | Virus Diseases | 3 | 2025 | 216 | 0.650 |
Why?
| | Health Personnel | 9 | 2022 | 742 | 0.590 |
Why?
| | Masks | 4 | 2025 | 70 | 0.510 |
Why?
| | Influenza Vaccines | 4 | 2024 | 529 | 0.460 |
Why?
| | Bacteremia | 6 | 2019 | 221 | 0.460 |
Why?
| | Respiratory Protective Devices | 3 | 2021 | 15 | 0.440 |
Why?
| | Hospitals, Pediatric | 6 | 2025 | 555 | 0.400 |
Why?
| | Population Surveillance | 4 | 2020 | 483 | 0.380 |
Why?
| | Disease Outbreaks | 6 | 2020 | 422 | 0.370 |
Why?
| | Disaster Planning | 3 | 2020 | 100 | 0.360 |
Why?
| | Influenza A virus | 3 | 2014 | 113 | 0.340 |
Why?
| | Influenza B virus | 2 | 2009 | 47 | 0.340 |
Why?
| | Vaccination | 6 | 2024 | 1422 | 0.330 |
Why?
| | Chemical Terrorism | 2 | 2020 | 4 | 0.320 |
Why?
| | Bioterrorism | 2 | 2020 | 31 | 0.310 |
Why?
| | Disease Notification | 1 | 2009 | 16 | 0.300 |
Why?
| | Health Care Surveys | 1 | 2010 | 538 | 0.280 |
Why?
| | Anti-Bacterial Agents | 4 | 2020 | 1906 | 0.280 |
Why?
| | Delivery of Health Care | 9 | 2022 | 940 | 0.260 |
Why?
| | Equipment Contamination | 3 | 2019 | 71 | 0.250 |
Why?
| | Mycoplasma hominis | 1 | 2006 | 4 | 0.250 |
Why?
| | Endocarditis, Bacterial | 1 | 2006 | 44 | 0.240 |
Why?
| | Medication Systems, Hospital | 1 | 2005 | 6 | 0.240 |
Why?
| | Enterovirus Infections | 3 | 2015 | 173 | 0.240 |
Why?
| | Forms and Records Control | 1 | 2005 | 20 | 0.230 |
Why?
| | Drug Utilization Review | 1 | 2005 | 61 | 0.230 |
Why?
| | Electronics | 1 | 2005 | 70 | 0.230 |
Why?
| | Visitors to Patients | 1 | 2025 | 11 | 0.230 |
Why?
| | Antibiotic Prophylaxis | 1 | 2005 | 129 | 0.210 |
Why?
| | Health Facilities | 1 | 2025 | 85 | 0.210 |
Why?
| | Humans | 49 | 2025 | 144261 | 0.200 |
Why?
| | Pandemics | 2 | 2022 | 1682 | 0.200 |
Why?
| | Child | 20 | 2025 | 22537 | 0.200 |
Why?
| | Surgical Procedures, Operative | 1 | 2005 | 268 | 0.190 |
Why?
| | Seasons | 5 | 2024 | 556 | 0.180 |
Why?
| | Genes, Immediate-Early | 1 | 2002 | 26 | 0.180 |
Why?
| | Coronavirus OC43, Human | 1 | 2021 | 7 | 0.180 |
Why?
| | Tuberculosis, Spinal | 1 | 2001 | 8 | 0.180 |
Why?
| | Personal Protective Equipment | 1 | 2022 | 57 | 0.180 |
Why?
| | Genes, Viral | 1 | 2002 | 90 | 0.180 |
Why?
| | Meningitis, Viral | 2 | 2011 | 20 | 0.170 |
Why?
| | Thoracic Vertebrae | 1 | 2001 | 79 | 0.170 |
Why?
| | Physician's Role | 2 | 2020 | 218 | 0.170 |
Why?
| | Cytotoxicity, Immunologic | 1 | 2002 | 223 | 0.170 |
Why?
| | Orthomyxoviridae Infections | 1 | 2022 | 72 | 0.170 |
Why?
| | Guideline Adherence | 1 | 2005 | 586 | 0.170 |
Why?
| | Virology | 2 | 2011 | 36 | 0.170 |
Why?
| | Cytomegalovirus | 1 | 2002 | 168 | 0.160 |
Why?
| | Colorado | 8 | 2020 | 4562 | 0.160 |
Why?
| | Enterovirus | 2 | 2011 | 82 | 0.160 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2022 | 157 | 0.160 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2002 | 202 | 0.160 |
Why?
| | Streptococcus pneumoniae | 3 | 2010 | 177 | 0.160 |
Why?
| | Hospitalization | 2 | 2015 | 2424 | 0.160 |
Why?
| | Civil Defense | 1 | 2020 | 21 | 0.160 |
Why?
| | Clostridium Infections | 1 | 2020 | 74 | 0.150 |
Why?
| | Serratia Infections | 1 | 2019 | 8 | 0.150 |
Why?
| | Infectious Disease Transmission, Patient-to-Professional | 1 | 2019 | 20 | 0.150 |
Why?
| | Child, Preschool | 12 | 2025 | 11774 | 0.150 |
Why?
| | Serratia marcescens | 1 | 2019 | 18 | 0.150 |
Why?
| | Practice Patterns, Physicians' | 2 | 1999 | 1347 | 0.150 |
Why?
| | Rotavirus Infections | 1 | 1999 | 35 | 0.150 |
Why?
| | Syringes | 1 | 2019 | 49 | 0.150 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2011 | 981 | 0.150 |
Why?
| | Viruses | 1 | 2021 | 165 | 0.140 |
Why?
| | Pediatricians | 1 | 2020 | 120 | 0.140 |
Why?
| | Killer Cells, Natural | 1 | 2002 | 467 | 0.140 |
Why?
| | Antimicrobial Stewardship | 1 | 2020 | 129 | 0.140 |
Why?
| | Heart Defects, Congenital | 1 | 2006 | 913 | 0.140 |
Why?
| | Mandatory Programs | 1 | 2018 | 16 | 0.140 |
Why?
| | Common Cold | 1 | 1998 | 15 | 0.140 |
Why?
| | Bronchitis | 1 | 1998 | 33 | 0.140 |
Why?
| | Social Participation | 1 | 2018 | 29 | 0.130 |
Why?
| | Communicable Diseases | 1 | 2020 | 163 | 0.130 |
Why?
| | Drug Utilization | 1 | 1998 | 166 | 0.130 |
Why?
| | Hospitals | 3 | 2023 | 727 | 0.130 |
Why?
| | United States | 13 | 2023 | 15876 | 0.120 |
Why?
| | Electronic Health Records | 2 | 2018 | 1169 | 0.120 |
Why?
| | Fatigue | 1 | 2018 | 361 | 0.120 |
Why?
| | Mutation | 1 | 2007 | 4085 | 0.120 |
Why?
| | Catheter-Related Infections | 1 | 2016 | 94 | 0.120 |
Why?
| | Spinal Fusion | 2 | 2013 | 260 | 0.110 |
Why?
| | Infant, Newborn | 5 | 2015 | 6424 | 0.110 |
Why?
| | Herpesvirus 2, Human | 1 | 1994 | 27 | 0.110 |
Why?
| | Occupational Diseases | 1 | 2016 | 164 | 0.110 |
Why?
| | Gram-Positive Bacterial Infections | 2 | 2012 | 69 | 0.100 |
Why?
| | Laryngeal Diseases | 1 | 1994 | 31 | 0.100 |
Why?
| | Enterovirus D, Human | 1 | 2015 | 87 | 0.100 |
Why?
| | Infant | 9 | 2025 | 10022 | 0.100 |
Why?
| | Acyclovir | 1 | 1994 | 96 | 0.100 |
Why?
| | Adult | 11 | 2020 | 40262 | 0.100 |
Why?
| | Adolescent | 10 | 2025 | 22281 | 0.100 |
Why?
| | Herpes Simplex | 1 | 1994 | 98 | 0.100 |
Why?
| | Exercise Therapy | 1 | 2018 | 467 | 0.100 |
Why?
| | Pertussis Vaccine | 1 | 2012 | 24 | 0.100 |
Why?
| | Bacillus cereus | 1 | 2012 | 5 | 0.090 |
Why?
| | Whooping Cough | 1 | 2012 | 55 | 0.090 |
Why?
| | Shock | 1 | 2013 | 108 | 0.090 |
Why?
| | Consensus | 3 | 2024 | 488 | 0.090 |
Why?
| | Guidelines as Topic | 1 | 2014 | 267 | 0.090 |
Why?
| | Quality Assurance, Health Care | 1 | 2014 | 336 | 0.090 |
Why?
| | Spinal Diseases | 1 | 2012 | 50 | 0.090 |
Why?
| | Age Distribution | 2 | 2010 | 397 | 0.090 |
Why?
| | Comorbidity | 1 | 2016 | 1646 | 0.090 |
Why?
| | Shock, Septic | 1 | 2013 | 215 | 0.090 |
Why?
| | Female | 19 | 2025 | 77976 | 0.090 |
Why?
| | Health Promotion | 1 | 2018 | 774 | 0.090 |
Why?
| | Male | 17 | 2025 | 72035 | 0.080 |
Why?
| | Decision Making | 1 | 2018 | 974 | 0.080 |
Why?
| | Ethics, Clinical | 1 | 2010 | 8 | 0.080 |
Why?
| | Online Systems | 1 | 2010 | 21 | 0.080 |
Why?
| | Health Planning | 1 | 2010 | 47 | 0.080 |
Why?
| | Decontamination | 2 | 2020 | 32 | 0.080 |
Why?
| | Ethics, Medical | 1 | 2010 | 86 | 0.080 |
Why?
| | Laboratories, Hospital | 1 | 2009 | 13 | 0.070 |
Why?
| | Orthopedic Procedures | 1 | 2012 | 242 | 0.070 |
Why?
| | Pneumococcal Infections | 1 | 2010 | 103 | 0.070 |
Why?
| | Software | 1 | 2014 | 690 | 0.070 |
Why?
| | Poison Control Centers | 2 | 2020 | 84 | 0.070 |
Why?
| | Gonorrhea | 1 | 2010 | 65 | 0.070 |
Why?
| | Chlamydia Infections | 1 | 2010 | 81 | 0.070 |
Why?
| | Epoprostenol | 1 | 2009 | 131 | 0.070 |
Why?
| | Clinical Laboratory Techniques | 1 | 2009 | 96 | 0.070 |
Why?
| | Young Adult | 5 | 2015 | 13990 | 0.070 |
Why?
| | Workload | 1 | 2010 | 170 | 0.070 |
Why?
| | Genetic Drift | 1 | 2007 | 6 | 0.070 |
Why?
| | Prescriptions | 1 | 2008 | 76 | 0.070 |
Why?
| | Catheterization, Central Venous | 1 | 2009 | 122 | 0.070 |
Why?
| | Ambulatory Care Facilities | 1 | 2010 | 264 | 0.070 |
Why?
| | Ethanol | 1 | 2012 | 625 | 0.060 |
Why?
| | Middle Aged | 7 | 2019 | 35762 | 0.060 |
Why?
| | Incidence | 4 | 2019 | 2870 | 0.060 |
Why?
| | Drug Resistance, Microbial | 2 | 1998 | 69 | 0.060 |
Why?
| | Patient Care Team | 1 | 2012 | 686 | 0.060 |
Why?
| | Respiratory System | 1 | 2007 | 149 | 0.060 |
Why?
| | Exercise | 1 | 2018 | 2193 | 0.060 |
Why?
| | Sexual Behavior | 1 | 2010 | 484 | 0.060 |
Why?
| | Pneumococcal Vaccines | 1 | 2006 | 130 | 0.060 |
Why?
| | Medical Audit | 1 | 2005 | 77 | 0.060 |
Why?
| | Antihypertensive Agents | 1 | 2009 | 509 | 0.060 |
Why?
| | Practice Guidelines as Topic | 1 | 2013 | 1559 | 0.060 |
Why?
| | Internet | 1 | 2010 | 698 | 0.060 |
Why?
| | Risk Factors | 5 | 2021 | 10699 | 0.050 |
Why?
| | Aged, 80 and over | 3 | 2015 | 8243 | 0.050 |
Why?
| | Program Evaluation | 3 | 2018 | 946 | 0.050 |
Why?
| | Delphi Technique | 2 | 2016 | 329 | 0.050 |
Why?
| | Ambulatory Care | 2 | 2019 | 597 | 0.050 |
Why?
| | Logistic Models | 3 | 2010 | 2104 | 0.050 |
Why?
| | Needs Assessment | 2 | 2020 | 401 | 0.050 |
Why?
| | Immunization Programs | 2 | 2018 | 193 | 0.050 |
Why?
| | Europe | 1 | 2024 | 412 | 0.050 |
Why?
| | Hemagglutination Inhibition Tests | 1 | 2022 | 38 | 0.050 |
Why?
| | Attitude of Health Personnel | 1 | 2010 | 1182 | 0.040 |
Why?
| | Influenza A Virus, H3N2 Subtype | 1 | 2022 | 50 | 0.040 |
Why?
| | Multivariate Analysis | 2 | 2010 | 1533 | 0.040 |
Why?
| | Patient Satisfaction | 2 | 2010 | 704 | 0.040 |
Why?
| | Pneumonia | 1 | 2006 | 630 | 0.040 |
Why?
| | Pediatrics | 2 | 2020 | 1112 | 0.040 |
Why?
| | Leadership | 1 | 2025 | 408 | 0.040 |
Why?
| | Surveys and Questionnaires | 2 | 2010 | 6021 | 0.040 |
Why?
| | Ricin | 1 | 2020 | 8 | 0.040 |
Why?
| | Smallpox | 1 | 2020 | 10 | 0.040 |
Why?
| | Government Agencies | 1 | 2020 | 14 | 0.040 |
Why?
| | Nerve Agents | 1 | 2020 | 7 | 0.040 |
Why?
| | Containment of Biohazards | 1 | 2020 | 21 | 0.040 |
Why?
| | Surge Capacity | 1 | 2020 | 16 | 0.040 |
Why?
| | Biological Factors | 1 | 2020 | 39 | 0.040 |
Why?
| | Asphyxia | 1 | 2020 | 23 | 0.040 |
Why?
| | Government Regulation | 1 | 2020 | 38 | 0.040 |
Why?
| | Irritants | 1 | 2020 | 38 | 0.040 |
Why?
| | Transfection | 1 | 2002 | 938 | 0.040 |
Why?
| | Health Care Costs | 2 | 2013 | 421 | 0.040 |
Why?
| | Attitude | 1 | 2021 | 259 | 0.040 |
Why?
| | Aged | 4 | 2015 | 25850 | 0.040 |
Why?
| | Gait | 1 | 2001 | 313 | 0.040 |
Why?
| | Viral Vaccines | 1 | 1999 | 107 | 0.030 |
Why?
| | Anthropology, Cultural | 1 | 2018 | 27 | 0.030 |
Why?
| | Airway Obstruction | 1 | 2020 | 162 | 0.030 |
Why?
| | Health Services Misuse | 1 | 1998 | 35 | 0.030 |
Why?
| | Heparin | 1 | 2019 | 243 | 0.030 |
Why?
| | Flow Cytometry | 1 | 2002 | 1172 | 0.030 |
Why?
| | Hypertension, Pulmonary | 1 | 2009 | 1980 | 0.030 |
Why?
| | Histocompatibility Antigens Class II | 1 | 1999 | 364 | 0.030 |
Why?
| | Antibodies, Viral | 1 | 2022 | 672 | 0.030 |
Why?
| | Absenteeism | 1 | 2018 | 52 | 0.030 |
Why?
| | Outpatients | 1 | 2021 | 439 | 0.030 |
Why?
| | Rhinitis | 1 | 1999 | 171 | 0.030 |
Why?
| | Research | 1 | 2020 | 428 | 0.030 |
Why?
| | Efficiency, Organizational | 1 | 2018 | 139 | 0.030 |
Why?
| | Nasopharyngeal Diseases | 1 | 1996 | 5 | 0.030 |
Why?
| | Lung Abscess | 1 | 1996 | 7 | 0.030 |
Why?
| | Fibroblasts | 1 | 2002 | 1032 | 0.030 |
Why?
| | Streptococcus pyogenes | 1 | 1996 | 41 | 0.030 |
Why?
| | Illinois | 1 | 2015 | 45 | 0.030 |
Why?
| | Missouri | 1 | 2015 | 66 | 0.030 |
Why?
| | Occupational Exposure | 1 | 2019 | 354 | 0.030 |
Why?
| | Environmental Exposure | 1 | 2020 | 587 | 0.030 |
Why?
| | Respiratory Sounds | 1 | 2015 | 105 | 0.030 |
Why?
| | Focus Groups | 1 | 2018 | 569 | 0.030 |
Why?
| | Maryland | 1 | 2014 | 65 | 0.030 |
Why?
| | Attitude to Health | 1 | 2018 | 434 | 0.030 |
Why?
| | Health Policy | 1 | 2018 | 398 | 0.030 |
Why?
| | Cough | 1 | 2015 | 124 | 0.030 |
Why?
| | Foscarnet | 1 | 1994 | 20 | 0.030 |
Why?
| | Interviews as Topic | 1 | 2018 | 898 | 0.030 |
Why?
| | Fever | 1 | 2015 | 311 | 0.030 |
Why?
| | Workplace | 1 | 2016 | 274 | 0.030 |
Why?
| | Streptococcal Infections | 1 | 1996 | 168 | 0.030 |
Why?
| | Dyspnea | 1 | 2015 | 251 | 0.030 |
Why?
| | Public Health Surveillance | 1 | 2013 | 83 | 0.020 |
Why?
| | Prevalence | 2 | 2010 | 2815 | 0.020 |
Why?
| | Mental Health | 1 | 2020 | 776 | 0.020 |
Why?
| | Prospective Studies | 2 | 2016 | 7970 | 0.020 |
Why?
| | Health Surveys | 1 | 2014 | 510 | 0.020 |
Why?
| | Product Recalls and Withdrawals | 1 | 2012 | 2 | 0.020 |
Why?
| | Molecular Typing | 1 | 2012 | 21 | 0.020 |
Why?
| | Retrospective Studies | 2 | 2012 | 17009 | 0.020 |
Why?
| | Algorithms | 1 | 2020 | 1834 | 0.020 |
Why?
| | Follow-Up Studies | 2 | 2012 | 5389 | 0.020 |
Why?
| | Case-Control Studies | 2 | 2010 | 3592 | 0.020 |
Why?
| | Scoliosis | 1 | 2013 | 223 | 0.020 |
Why?
| | Elective Surgical Procedures | 1 | 2012 | 201 | 0.020 |
Why?
| | Cerebrospinal Fluid | 1 | 2010 | 88 | 0.020 |
Why?
| | Respiration, Artificial | 1 | 2015 | 707 | 0.020 |
Why?
| | Contact Tracing | 1 | 2010 | 26 | 0.020 |
Why?
| | Vaccines, Conjugate | 1 | 2010 | 60 | 0.020 |
Why?
| | San Francisco | 1 | 2010 | 60 | 0.020 |
Why?
| | Qualitative Research | 1 | 2018 | 1659 | 0.020 |
Why?
| | Gram-Positive Bacteria | 1 | 2009 | 47 | 0.020 |
Why?
| | Critical Care | 1 | 2015 | 694 | 0.020 |
Why?
| | Lung Diseases | 1 | 1996 | 787 | 0.020 |
Why?
| | Sex Distribution | 1 | 2010 | 380 | 0.020 |
Why?
| | Diagnosis, Differential | 1 | 2013 | 1487 | 0.020 |
Why?
| | Primary Health Care | 1 | 2020 | 1710 | 0.020 |
Why?
| | Gram-Negative Bacterial Infections | 1 | 2009 | 51 | 0.020 |
Why?
| | Gram-Negative Bacteria | 1 | 2009 | 81 | 0.020 |
Why?
| | Catheters, Indwelling | 1 | 2009 | 96 | 0.020 |
Why?
| | Reference Values | 1 | 2010 | 797 | 0.020 |
Why?
| | Infusions, Intravenous | 1 | 2009 | 423 | 0.020 |
Why?
| | Sex Factors | 1 | 2013 | 2096 | 0.020 |
Why?
| | Risk Reduction Behavior | 1 | 2009 | 225 | 0.020 |
Why?
| | Serotyping | 1 | 2006 | 32 | 0.020 |
Why?
| | Urban Population | 1 | 2010 | 490 | 0.020 |
Why?
| | RNA, Viral | 1 | 2010 | 687 | 0.020 |
Why?
| | Age Factors | 1 | 2013 | 3313 | 0.010 |
Why?
| | Length of Stay | 1 | 2012 | 1335 | 0.010 |
Why?
| | Sensitivity and Specificity | 1 | 2010 | 1983 | 0.010 |
Why?
| | Socioeconomic Factors | 1 | 2010 | 1312 | 0.010 |
Why?
| | Immunization Schedule | 1 | 2006 | 187 | 0.010 |
Why?
| | Asthma | 1 | 2015 | 1767 | 0.010 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2010 | 1409 | 0.010 |
Why?
| | Time Factors | 1 | 2010 | 7155 | 0.010 |
Why?
| | Gallium Radioisotopes | 1 | 1996 | 15 | 0.010 |
Why?
| | Retropharyngeal Abscess | 1 | 1996 | 7 | 0.010 |
Why?
| | Radionuclide Imaging | 1 | 1996 | 112 | 0.010 |
Why?
| | Tomography, X-Ray Computed | 1 | 1996 | 2730 | 0.000 |
Why?
|
|
Nyquist's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|